Healing Ointment Usage Post-surgical Procedure (Cetaphil)

Galderma

Status and phase: Completed; Phase 4

Conditions: Surgical Wound

Treatments: Drug: Cetaphil Healing Ointment

Study type: Interventional

Funder types: Industry

Identifiers

NCT05686928

GLI.04.US.SL.017

Details and patient eligibility

About

To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures

Full description

This is an open-label, multi-center study to evaluate the safety and efficacy of a Healing Ointment in skin improvement after dermatologic procedures such as Mohs surgery, skin biopsy, excision on the head/neck or body.

The study is designed to enroll approximately 20 subjects, in which 10 subjects undergo dermatologic procedure on the head/neck and 10 subjects on the body.

Eligible subjects apply the test product twice daily after the procedure, followed by efficacy and tolerability assessments, standard photography, and self-assessment questionnaire at each follow-up visit.

Enrollment: 15 patients

Sex: All

Ages: 18 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subject who undergo Mohs surgery, skin biopsy, excision on the head/neck or body
• Ability of giving consent for participation in the study
• Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments

Exclusion criteria

• History of allergy or hypersensitivity to cosmetic ingredients
• Pregnant, planning pregnancy during the course of the study or breastfeeding
• Subject with a history of keloids or hypertrophic scars
• Presence of tattoo and/or scar in the treatment area that in the investigator's opinion would interfere with study assessments
• Subjects with history of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) at the discretion of the investigator
• Subjects with inability to comply with all study protocol restrictions and visits

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Healing Ointment

Experimental group

Description:

Petrolatum-based opaque ointment applied to surgical wound twice daily.

Treatment:

Drug: Cetaphil Healing Ointment